296 related articles for article (PubMed ID: 19945236)
41. Subchorionic hemorrhage treatment with dydrogesterone.
Pelinescu-Onciul D
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():77-81. PubMed ID: 17943544
[TBL] [Abstract][Full Text] [Related]
42. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
[TBL] [Abstract][Full Text] [Related]
43. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
Stute P
Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
[TBL] [Abstract][Full Text] [Related]
44. Do we need to follow up complete miscarriages with serum human chorionic gonadotrophin levels?
Condous G; Okaro E; Khalid A; Bourne T
BJOG; 2005 Jun; 112(6):827-9. PubMed ID: 15924545
[TBL] [Abstract][Full Text] [Related]
45. The role of dydrogesterone in recurrent (habitual) abortion.
Gruber CJ; Huber JC
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
[TBL] [Abstract][Full Text] [Related]
46. Progestogen for treating threatened miscarriage.
Wahabi HA; Abed Althagafi NF; Elawad M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005943. PubMed ID: 17636813
[TBL] [Abstract][Full Text] [Related]
47. Association between low day 16 hCG and miscarriage after proven cardiac activity.
Tong S; Wallace EM; Rombauts L
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):300-4. PubMed ID: 16449115
[TBL] [Abstract][Full Text] [Related]
48. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutics basis of threatened abortions (author's transl)].
Viala JL
J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):678-82. PubMed ID: 29925
[TBL] [Abstract][Full Text] [Related]
50. Spontaneous abortion and ectopic pregnancy.
Avant RF
Prim Care; 1983 Jun; 10(2):161-72. PubMed ID: 6554828
[TBL] [Abstract][Full Text] [Related]
51. A systematic review of dydrogesterone for the treatment of recurrent miscarriage.
Carp H
Gynecol Endocrinol; 2015 Jun; 31(6):422-30. PubMed ID: 25765519
[TBL] [Abstract][Full Text] [Related]
52. Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone.
Czajkowski K; Sienko J; Mogilinski M; Bros M; Szczecina R; Czajkowska A
Fertil Steril; 2007 Mar; 87(3):613-8. PubMed ID: 17126337
[TBL] [Abstract][Full Text] [Related]
53. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.
Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL
Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598
[TBL] [Abstract][Full Text] [Related]
54. Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.
Ioannidis G; Sacks G; Reddy N; Seyani L; Margara R; Lavery S; Trew G
Hum Reprod; 2005 Mar; 20(3):741-6. PubMed ID: 15591085
[TBL] [Abstract][Full Text] [Related]
55. Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: A cross-sectional analysis.
Pang YY; Ma CL
J Clin Pharm Ther; 2022 Feb; 47(2):228-236. PubMed ID: 34704273
[TBL] [Abstract][Full Text] [Related]
56. Physiology should be supported with evidence in progesterone administration for threatened miscarriage.
Sotiriadis A; Makrydimas G
Am J Reprod Immunol; 2005 Oct; 54(4):240. PubMed ID: 16135015
[No Abstract] [Full Text] [Related]
57. Clinical value of a single serum CA-125 level in women with symptoms of imminent abortion during the first trimester of pregnancy.
Fiegler P; Katz M; Kaminski K; Rudol G
J Reprod Med; 2003 Dec; 48(12):982-8. PubMed ID: 14738027
[TBL] [Abstract][Full Text] [Related]
58. [Current status of gestagen administration. 2. Gestagen therapy in the area of reproduction].
Völker W
Fortschr Med; 1977 Jan; 95(2):68-70. PubMed ID: 556711
[TBL] [Abstract][Full Text] [Related]
59. Novel approach using serum progesterone as a triage to guide management of patients with threatened miscarriage: a prospective cohort study.
Tan TC; Ku CW; Kwek LK; Lee KW; Zhang X; Allen JC; Zhang VR; Tan NS
Sci Rep; 2020 Jun; 10(1):9153. PubMed ID: 32499581
[TBL] [Abstract][Full Text] [Related]
60. Progestogen for treating threatened miscarriage.
Wahabi HA; Abed Althagafi NF; Elawad M; Al Zeidan RA
Cochrane Database Syst Rev; 2011 Mar; (3):CD005943. PubMed ID: 21412891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
